PATENT CLAIM ANALYSIS

Application Number: 15910876
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "005900"]

Abstract:
Disclosed herein are improved methods of treating hyperglycemia with a combination of an ultrarapid acting insulin and insulin glargine comprising prandial administration of the ultrarapid insulin, and administration of a first dose of insulin glargine within 6 hours of waking for a day.

Claim (Index 1):
A method of treating diabetes type 2, comprising: selecting a patient with diabetes type 2 currently being treated with a suppressor of hepatic glucose output but not a basal insulin who is in need of improved glycemic control and who would be a candidate for combination treatment with said suppressor of hepatic glucose output and an insulin secretagogue; and instead combining treatment with said suppressor of hepatic glucose output with routinely administering an ultrarapid acting insulin (URAI) preparation with at least one established meal, wherein the suppressor of hepatic glucose is metformin.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 90.0
- Lexical Diversity: 1.45161
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12539459', '13351855', '14102383', '13357821', '15421743']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8225507682442407
- 35 USC 102 Novelty (BERT): 0.6969571876386604
- Combined Prediction Score: 0.8099914101836827
- Mean Citation Score: 697.768908
- Max Citation Score: 723.9169
- Similarity Product: 715.9990934252977

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test